Literature DB >> 6692398

Enhanced metastatic potential of cloned low-metastatic Lewis lung carcinoma cells treated in vitro with dimethyl sulfoxide.

K Takenaga.   

Abstract

Treatment of low-metastatic Lewis lung carcinoma cells (P-29) with dimethyl sulfoxide in vitro enhanced their lung-colonizing ability. The concentration of dimethyl sulfoxide used delayed the in vitro growth of P-29 cells but was not cytotoxic. The arrest and retention in the lung of untreated and dimethyl sulfoxide-treated P-29 cells labeled with 5-[125I]iodo-2'-deoxyuridine after injecting them into a tail vein of syngeneic mice were examined. Dimethyl sulfoxide-treated P-29 cells were trapped in the lung more than untreated cells and were cleared from the lungs more slowly than untreated cells. Treatment of P-29 cells with dimethyl sulfoxide resulted in the increase in their homotypic aggregation and adhesion to plastic culture dishes, monolayers of endothelial cells, and a subendothelial extracellular matrix. This treatment also increased significantly their activities of degradative enzymes, such as glycosidases and cathepsin B, and their production of plasminogen activator. These results indicate that the enhanced lung-colonizing ability of P-29 cells treated with dimethyl sulfoxide is due to the increase in adhesiveness, resulting in arrest and retention of the cells in the lung of the host and in the increase in their degradative enzyme activities. The enhancing effect of dimethyl sulfoxide on the lung-colonizing ability of P-29 cells was found to be reversible.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692398

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Resistance to apoptosis induced by microenvironmental stresses is correlated with metastatic potential in Lewis lung carcinoma.

Authors:  M Takasu; Y Tada; J O Wang; M Tagawa; K Takenaga
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

Review 2.  Modification of the metastatic potential of tumor cells by drugs.

Authors:  K Takenaga
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

3.  Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases.

Authors:  K Yamasaki; S Sone; T Yamashita; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 4.  Cell-contact and -architecture of malignant cells and their relationship to metastasis.

Authors:  A Raz; A Ben-Ze'ev
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  The effect of butyric acid and retinoic acid on invasion and experimental metastasis of murine melanoma cells.

Authors:  T W McGarvey; S Silberman; B Persky
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

6.  Malignant and other properties of human colon carcinoma cells after suppression of sulfomucin production in vitro.

Authors:  H Tsuiji; S Nakatsugawa; T Ishigaki; T Irimura
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

7.  DMSO-induced changes in the procoagulant and fibrinolytic activity of B16 melanoma cells: influence on lung colony formation.

Authors:  B Casali; M G Lampugnani; M Riganti; A Niewiarowska; G Alessio; L Mussoni; N Semeraro; M B Donati
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

Review 8.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Modulation of invasive potential in different clonal subpopulations of a rat rhabdomyosarcoma cell line (BA-HAN-1) by differentiation induction.

Authors:  C D Gerharz; M E Bracke; M M Mareel; H E Gabbert
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

10.  Repression of stromelysin metalloprotease expression in rat fibrosarcoma cells by dimethylsulfoxide.

Authors:  P Popowicz; G Engel; H Marshall; S Linder
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.